Skip to main content
Clinical Trials/NCT02834676
NCT02834676UnknownNot Applicable

Retrospective Evaluation of Treatment of Chronic Pain Related to Cervical Disc Hernia Using Chemonucleolysis Substance

Sakarya University1 site in 1 country35 target enrollmentStarted: June 2016Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
35
Locations
1
Primary Endpoint
DiscoGel technique for pain relief assessed by Statistical Package for the Social Sciences (SPSS) v22.0

Study Overview

Brief Summary

The aim of the study is to evaluate the clinical effects of Discogel® Radiopaque Gelified Ethanol as therapeutic substance for nucleolysis application in the patients with cervical disc hernia who had chronic pain and weakness on the neck, shoulders and arms.

Detailed Description

This is a retrospective, single-center study that is going to be conducted from November 2013 to May 2016 on patients visiting the pain clinic of the hospital who were treated with DiscoGel® for cervical discogenic or radicular pain that did not resolve after the use of conventional therapy and ozone-oxygen therapy.

Data collected from medical record forms and electronic medical record system of the hospital were used in the retrospective analysis of medical data with regard to age, gender, complications.

A resident who has not involved in the study interviewed each patient by telephone on the follow up to collect the related information.

Study Design

Study Type
Observational
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • continuous radicular pain radiating to the upper limb, with a duration ≥8 weeks and an intensity >4/10 as rated by the patient on a visual analog scale (VAS)
  • resistant to appropriate conservative treatment combining anti-inflammatory drugs and ozone-oxygen therapy, and confirmed by imaging with CT or MRI of a herniated disc putting pressure on a nerve root consistent with the clinical pain.

Exclusion Criteria

  • history of surgery at the cervical spine, contraindication to percutaneous chemonucleolysis (coagulopathy or infection), imaging results that did not support the clinical results, the presence of a herniated disc excluded or calcified on imaging, possible interference with pain evaluation due to any medical condition or treatment, involvement of incomplete data collection

Arms & Interventions

Chemonucleolysis by Gelified Ethanol

Patients visiting the pain clinic of the hospital who had cervical discogenic or radicular pain that did not resolve after the use of conventional therapy and ozone-oxygen therapy. Written informed consent was obtained from all participants.

Intervention: Gelified Ethanol (Drug)

Outcomes

Primary Outcomes

DiscoGel technique for pain relief assessed by Statistical Package for the Social Sciences (SPSS) v22.0

Time Frame: 1 month

Statistical assessment of each patient was evaluated on time intervals before procedure, in the 1st month after procedure for Visual analogue scale (VAS) score for pain

Secondary Outcomes

  • Assessment of degree of disability and estimating quality of life based on Oswestry Disability Index (ODI) score by SPSS v22.0(1 month)
  • DiscoGel technique for pain relief assessed by Statistical Package for the Social Sciences (SPSS) v22.0(3 months)

Investigators

Sponsor
Sakarya University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Havva Sayhan

Assistant Professor

Sakarya University

Study Sites (1)

Loading locations...

Similar Trials